The frontal cortex is one of the primary brain regions affected in frontotemporal dementia (FTD), and degeneration of frontal cortical neurons is a hallmark of the disease. FTD encompasses a group of disorders characterized by progressive neuronal loss in the frontal and temporal lobes, leading to changes in personality, behavior, and language 1.
The frontal cortex contains six distinct neuronal layers, and certain layers show particular vulnerability in FTD:
- Layer II (External granular layer): Contains small pyramidal neurons that are early targets in FTD
- Layer III (External pyramidal layer): Medium pyramidal neurons show significant degeneration
- Layer V (Internal pyramidal layer): Large pyramidal neurons projecting to subcortical structures are affected
- Layer VI (Multiform layer): Projection neurons connecting to thalamus show pathology
Frontal cortical pyramidal neurons are particularly vulnerable in FTD due to:
- Tau pathology: Hyperphosphorylated tau accumulates within neurons, forming neurofibrillary tangles
- TDP-43 pathology: Most FTD cases (except those with MAPT mutations) show TDP-43 inclusions
- Axonal transport defects: Impaired trafficking leads to synaptic dysfunction
- Energy metabolism failure: Mitochondrial dysfunction contributes to neuronal death
In cases of FTD with MAPT mutations, the 3-repeat tau isoform accumulates preferentially in the frontal cortex. Key pathological features include:
- Pick bodies: Spherical tau inclusions in neurons
- Astrocytictau pathology: Astrocytes show tau deposits
- Neuronal loss: Severe depletion of pyramidal neurons in advanced stages
The majority of sporadic FTD cases show TDP-43 pathology:
- Type A: Most common, characterized by moderate to numerous neuronal cytoplasmic inclusions
- Type B: Characterized by few inclusions but extensive neuronal loss
- Type C: Characterized by long neurites and sparse inclusions
The tau phosphorylation cascade in FTD involves:
- Kinase activation: GSK-3β, CDK5, and MARK are upregulated
- Phosphatase dysfunction: PP2A activity is reduced
- Tau misfolding: Hyperphosphorylated tau aggregates into oligomers
- Aggregate formation: Oligomers form insoluble fibrils and NFTs
Neuronal proteostasis systems are compromised:
Degeneration of orbitofrontal cortex neurons correlates with:
- Disinhibition and inappropriate social behavior
- Loss of executive function
- Impairments in decision-making
Temporal and frontal language network neurons are affected:
- Broca's area neuron loss causes non-fluent speech
- Wernicke's area involvement causes language comprehension deficits
- Tau-targeted therapies: Anti-tau antibodies and small molecule inhibitors
- Neuroprotective agents: Mitochondrial protectors, antioxidants
- Synaptic stabilization: AMPA receptor modulators
- Gene therapy: AAV-delivered anti-tau constructs
- Cell replacement: Stem cell-based approaches to replace lost neurons
- Network modulation: Deep brain stimulation to compensate for neuronal loss
- [frontotemporal dementia (FTD)frontotemporal-dementia)frontotemporal-dementia)
- [Frontal cortical pyramidal neurons
](/cell-types/frontal-cortical-pyramidal-neurons)## External Links